Supriya Lifescience Limited (SUPRIYA.NS)
INR 745.45
(0.21%)
INR 745.45
(0.21%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -694.68 Million INR | -10.65% |
| 2022 | -627.83 Million INR | 54.62% |
| 2021 | -1.38 Billion INR | -436.46% |
| 2020 | 411.22 Million INR | -50.44% |
| 2019 | 829.77 Million INR | -8.45% |
| 2018 | 906.38 Million INR | -28.99% |
| 2017 | 1.27 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -772.14 Million INR | 0.0% |
| 2024 Q1 | - INR | 100.0% |
| 2023 FY | -694.68 Million INR | -10.65% |
| 2023 Q1 | 1.57 Billion INR | 350.99% |
| 2023 Q4 | -694.68 Million INR | -159.99% |
| 2023 Q3 | 1.15 Billion INR | 217.85% |
| 2023 Q2 | -982.7 Million INR | -162.36% |
| 2022 Q4 | -627.83 Million INR | -133.12% |
| 2022 Q3 | 1.89 Billion INR | 305.09% |
| 2022 Q2 | -924.34 Million INR | -139.51% |
| 2022 Q1 | 2.33 Billion INR | 269.08% |
| 2022 FY | -627.83 Million INR | 54.62% |
| 2021 Q2 | 705.33 Million INR | 0.0% |
| 2021 FY | -1.38 Billion INR | -436.46% |
| 2021 Q4 | -1.38 Billion INR | 0.0% |
| 2020 Q3 | 596.27 Million INR | 0.0% |
| 2020 FY | 411.22 Million INR | -50.44% |
| 2020 Q4 | 411.22 Million INR | -31.03% |
| 2019 FY | 829.77 Million INR | -8.45% |
| 2018 FY | 906.38 Million INR | -28.99% |
| 2017 FY | 1.27 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Biocon Limited | 140.18 Billion INR | 100.496% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 16.397% |
| Concord Biotech Limited | -54.04 Million INR | -1185.373% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 103.658% |
| Jubilant Ingrevia Limited | 6.6 Billion INR | 110.515% |
| Lyka Labs Limited | 527.01 Million INR | 231.815% |
| Panacea Biotec Limited | -1.18 Billion INR | 41.372% |
| Piramal Pharma Limited | 42.27 Billion INR | 101.643% |
| SMS Lifesciences India Limited | 992.31 Million INR | 170.006% |
| Syngene International Limited | -83 Million INR | -736.964% |
| TAKE Solutions Limited | 361.37 Million INR | 292.235% |
| Zota Health Care Limited | 942.79 Million INR | 173.683% |